Bio-Techne

The R&D Systems™ website now brings together products from R&D Systems, Novus Biologicals™, and Tocris Bioscience™. Browse and compare proteins, antibodies, ELISAs, and small molecules, and access supporting data, all in one place. Explore now: https://bit.ly/4m3BsF4

Last week, our CEO Kim Kelderman visited China to meet with customers who are driving remarkable breakthroughs in science and medicine, from the latest advances in the cell therapy industry to the frontline of spatiotemporal omics research. During a China team town hall, Kim celebrated our customers’ success as well as our strong consecutive‑quarter growth in the region, made possible by the dedication and creativity of our local team. We’re proud to partner with the scientists, innovators, and institutions shaping the future of global science. And we’re even more excited for what’s to come, as we continue to strengthen our presence in the region.

At #analytica 2026, it’s all about digital transformation, AI, and sustainability. Hear from Jean-François Bellec on what we’re seeing and sharing on the ground about the latest analytical techniques and instrumentation. 

We are advancing our spatial biology capabilities on the COMET™ platform with the introduction of new SPYRE™ Focus Panels and SPYRE Amplification Kits. These additions strengthen our modular, automated spatial biology workflow, delivering greater flexibility and sensitivity and more biologically meaningful data, from initial assay design through final interpretation. Together, they further reinforce the fully integrated COMET spatial biology ecosystem, supporting consumable adoption, panel expansion, and platform pull-through. Read the full press release: https://bit.ly/4t26RtG #SpatialBiology

Momentum is building behind fluid biomarkers as a core part of Alzheimer’s research and therapy development. Last week at #ADPD2026, we saw this first-hand.   It was inspiring to hear blood biomarkers discussed, not just for diagnosis, but to support triage, improve risk prediction and future treatment choices.   We were also excited to present data supporting Alzheimer’s fluid biomarker quantification using our recently launched Simple Plex Ultra-Sensitive assays, and to continue empowering the scientific community to advance neurodegenerative disease research.   #Alzheimers #Neuroscience

Congratulations to Cheryl Bethune, our Chief Human Resources Officer, on being named a 2026 Celebrating The Sistas honoree! These awards shine a light on Black women leaders in Minnesota, who are shaping the future of workplaces and communities by inspiring others and driving change and impact. We’re proud to have Cheryl on our leadership team, where she brings global insights, deep HR expertise and visionary leadership, along with a passion for building high-performing teams and a thriving company culture. Congratulations to Cheryl and all this year’s honorees, and a big thank you to Sharon Smith-Akinsanya and her team at Rae Mackenzie Group, Inc. for a great event!

At Advanced Therapies UK, one thing was clear: collaboration across this complex ecosystem, from CDMOs to regulatory bodies to patient advocacy groups, is essential to bringing cell and gene therapies to patients.   It was inspiring to connect with the community, see how cell therapy is diversifying into new disease areas and explore how analytics can keep pace with technological advances to support regulatory readiness and patient safety.   A special thank you to Alexandre Lucas, Founder and Manager of We-Met Platform at I2MC, for an insightful talk on mitigating assay design risks for clinical trial readiness. It was great to hear how our Simple Western™ Technology and Ella™ Automated ELISA Platform are helping streamline and strengthen assay development in this evolving regulatory landscape.   Innovation in advanced therapies is moving fast, and we’re proud to contribute to the ecosystem, shaping the next generation of treatments.   #AdTherapies #CellTherapy #GeneTherapy #ATMPs

Proud to see researchers leveraging our COMET™ automated spatial biology platform in this impactful collaboration between Microsoft, Providence, and the University of Washington. Exciting to see how spatial biology and AI are opening new possibilities for predicting disease progression and treatment response. 

Finding the right reagent just got easier. We recently upgraded our R&D Systems™ website, so you can browse products from R&D Systems, Novus Biologicals™, and Tocris Bioscience™ in one place, with all the supporting data you need. Explore now: https://bit.ly/4sd649c

Yesterday, we kicked off The Spatial Biology Week™ 2026 – a global, five‑day virtual symposium bringing together researchers, clinicians, and industry leaders to explore the evolving landscape of spatial biology. As hosts, we’re committed to supporting open dialogue that accelerates advancements in spatial technologies and their impact across research and clinical applications. The week ahead will feature sessions covering immunology and infectious disease, neurobiology, biopharma applications, and spatial validation for diagnostics and biomarkers. Register now: https://bit.ly/3Pbqr86 #SpatialBiology #SBW2026